4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001193125-26-264038
Chief Executive Officer sold 49,670 shares at $241.01 ($11,970,967)
- Chief Executive Officer acquired 49,670 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
TABUTEAU HERRIOT · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-09 | Exercise or conversion : show line 1 in the form 10b5-1 | +49,670 | $4.95 | $245,867 | 56,899 | D |
| 2026-06-09 | Sale : show line 2 in the form 10b5-1 | −49,670 | $241.01 | $11,970,967 | 7,229 | D |
| Open-market sales · 49,670 sh · avg $241.01 · $11,970,967 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-09 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −49,670 | 99,330 | D |
Loading xslF345X06/ownership.xml…